tiprankstipranks
Intra-Cellular reports Q4 EPS (16c), consensus (11c)
PremiumThe FlyIntra-Cellular reports Q4 EPS (16c), consensus (11c)
1M ago
Intra-Cellular downgraded to Hold from Buy at Canaccord
Premium
The Fly
Intra-Cellular downgraded to Hold from Buy at Canaccord
2M ago
Johnson & Johnson says positioned for 5%-7% growth through 2030 and beyond
Premium
The Fly
Johnson & Johnson says positioned for 5%-7% growth through 2030 and beyond
2M ago
Intra-Cellular downgraded to Neutral from Overweight at Piper Sandler
PremiumThe FlyIntra-Cellular downgraded to Neutral from Overweight at Piper Sandler
3M ago
Intra-Cellular downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
Intra-Cellular downgraded to Market Perform from Outperform at Leerink
3M ago
BofA moves to No Rating on Intra-Cellular after Johnson & Johnson deal
Premium
The Fly
BofA moves to No Rating on Intra-Cellular after Johnson & Johnson deal
3M ago
Intra-Cellular downgraded to Hold from Buy at Needham
PremiumThe FlyIntra-Cellular downgraded to Hold from Buy at Needham
3M ago
Intra-Cellular downgraded to Equal Weight from Overweight at Morgan Stanley
Premium
The Fly
Intra-Cellular downgraded to Equal Weight from Overweight at Morgan Stanley
3M ago
Morning Movers: Intra-Cellular surges following deal to be bought by J&J
Premium
The Fly
Morning Movers: Intra-Cellular surges following deal to be bought by J&J
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100